Remifentanil

Current Opinion in Critical Care

Volumn 7, Issue 4, 2001, Pages 227-231

  Cohen, Jeremy ^a   Royston, David ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; PROPOFOL; REMIFENTANIL;

ANALGESIA; CLINICAL TRIAL; DRUG CLEARANCE; DRUG COST; DRUG MECHANISM; DRUG METABOLISM; DRUG USE; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; PEROPERATIVE CARE; REVIEW; SEDATION;

HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; PIPERIDINES;

EID: 0034836474     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200108000-00003     Document Type: Review

References (32)

1. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B)
2. A review of the pharmacokinetics and pharmacodynamics of remifentanil
3. A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery
4. Severe cardiovascular depression with remifentanil
5. Remifentanil based total intravenous anesthesia (TIVA) in primary CABG surgery patients: Use as a sole induction agent and haemodynamic responses throughout surgery
6. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil
7. Measured context-sensitive half-times of remifentanil and alfentanil
8. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease
9. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers
10. Influence of hemorrhagic shock on remifentanil: A pharmacokinetic and pharmacodynamic analysis
11. Sedation in the intensive care unit
12. Alterations in metabolism following injury: Part I
13. Effect of analgesic treatment on the physiologic consequences of acute pain
14. Intensive care sedation: A review of current British practice
15. A comparison of two constant-dose continuous infusions of remifentanil for severe postoperative pain
16. A multicenter evaluation of remifentanil for early postoperative analgesia
17. Remifentanil in the critically ill
18. Intact cerebral blood flow reactivity during remifentanil/nitrous oxide anesthesia
19. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions
20. Cerebral blood flow and CO2 reactivity is similar during remifentanil/N2O and fentanyl/N2O anesthesia
21. Intracranial pressure and hemodynamic effects of remifentanil versus alfentanil in patients undergoing supratentorial craniotomy
22. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit
23. A comparison of remifentanil and fentanyl in patients undergoing carotid endarterectomy
24. Postoperative myocardial ischemia: Therapeutic trials using intensive analgesia following surgery
25. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery
26. Inpatient experience with remifentanil
27. Extubation following CABG using remifentanil based total intravenous anesthesia (TIVA)
28. Early vs conventional extubation after cardiac surgery with cardiopulmonary bypass
29. Cost analysis of target-controlled infusion-based anesthesia compared with standard anesthesia regimens
30. Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care
31. Propofol sparing effect of remifentanil when added to propofol for sedation in the intensive care unit
32. Reducing the demand for admission to intensive care after major abdominal surgery by a change in anesthetic practice and the use of remifentanil